Published Jun 1, 2023
Adapting Biopharma to AI with Greg Meyers
Greg Meyers, EVP and Chief Digital and Technology Officer at Bristol Myers Squibb, joins Jorge Conde to explore the transformative impact of AI on biopharma, emphasizing its role in revolutionizing disease diagnosis, drug discovery, and clinical trials through innovations in remote monitoring and wearables, as well as the importance of strategic partnerships in fostering biotechnology advancements.
